Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Operating Leases Lessee, Operating Leases [Text Block] Document Type Document Type Options, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Investment income, net Other Nonoperating Income (Expense) Municipal debt securities US States and Political Subdivisions Debt Securities [Member] Contingencies Commitments and Contingencies Disclosure [Text Block] Accretion on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Treasury Stock Treasury Stock [Member] Estimated Fair Value Total estimated fair value Debt Securities, Available-for-sale Estimated Fair Value Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract] Net proceeds from issuance of common stock Proceeds from Issuance or Sale of Equity Statement, Equity Components [Axis] Equity Components [Axis] Restricted Stock Restricted Stock [Member] Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Warrants, Vested and expected to vest (in shares) shares, vested and expected to vest shares, vested and expected to vest Proceeds from sale of NOLs Proceeds From Sale Of Net Operating Losses, NJEDA Program Proceeds From Sale Of Net Operating Losses, NJEDA Program Greater than one year Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Level 3 Fair Value, Inputs, Level 3 [Member] Warrants, Exercised (in dollars per share) Weighted Average Exercise Price, Warrants Exercised Weighted Average Exercise Price, Warrants Exercised Balance Sheet Location [Domain] Balance Sheet Location [Domain] Sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Operating lease liabilities -- current Operating lease liabilities, current Operating Lease, Liability, Current LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Options, Vested, Weighted Average Remaining Contractual Term Options, Vested, weighted Average Remaining Contractual Term Options, Vested, weighted Average Remaining Contractual Term Stock Options Activity [Domain] Stock Options Activity [Domain] Stock Options Activity [Domain] Schedule of Fair Value of Share-based Compensation Awards Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Warrants, Expired (in shares) Warrants Expired Warrants Expired Series B Convertible Preferred Stock Preferred Stock [Member] Options, Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Security Exchange Name Security Exchange Name Fair Value Measurements Fair Value Disclosures [Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Warrants, Exercised (in shares) Warrants Exercised Warrants Exercised Schedule of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Share-Based Compensation Share-based Payment Arrangement [Policy Text Block] Operating loss Operating Income (Loss) Warrants Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Adoption of new accounting standard Cumulative Effect, Period of Adoption, Adjustment [Member] Total current liabilities Liabilities, Current Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Weighted average discount rate for operating leases (percent) Operating Lease, Weighted Average Discount Rate, Percent Prepaid and other current assets Prepaid Expense and Other Assets, Current Options, Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Commitments and Contingencies Commitments and Contingencies Warrants, Vested, Weighted Average Exercise Price (in dollars per share) Weighted Average Exercise Price, Warrants Exercisable Weighted Average Exercise Price, Warrants Exercisable ASSETS Assets [Abstract] Vesting terms (years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounting Policies [Abstract] Accounting Policies [Abstract] Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based compensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Entity Address, State or Province Entity Address, State or Province Stock Options and Warrants [Line Items] Class of Warrant or Right [Line Items] Less: Amounts representing interest Finance Lease, Liability, Undiscounted Excess Amount Accounts payable Accounts Payable, Current Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Research and development Research and Development Expense [Member] Number of shares allowable to direct for Regular Purchase (in shares) Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase Warrants, Vested (in shares) Warrants, Vested Warrants, Vested Accumulated deficit Retained Earnings (Accumulated Deficit) Right-of-use assets Operating Lease, Right-of-Use Asset Accrued liabilities Accrued Liabilities [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Total lease payments Lessee, Operating Lease, Liability, to be Paid Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Deferred Revenue Arrangement, by Type [Table] Deferred Revenue Arrangement, by Type [Table] Research and Development [Abstract] Research and Development [Abstract] 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Sovereign government securities Sovereign Debt [Member] Options, Outstanding, Beginning of Period (in shares) Options, Outstanding, End of Period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number The Business The Business [Text Block] The Business [Text Block] Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Maximum beneficial ownership allowable per agreement (percent) Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Sale of Stock [Axis] Sale of Stock [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Maximum obligation per directed purchase transaction for Regular Purchase Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase Basic and diluted shares Weighted Average Number of Shares Outstanding, Basic and Diluted Beginning Balance (shares) Ending Balance (shares) Shares, Outstanding Warrants, Vested, Weighted Average Remaining Contractual Term weighted Average Remaining Contractual Term, warrants vested weighted Average Remaining Contractual Term, warrants vested Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2020 and December 31, 2019, respectively Preferred Stock, Value, Issued Cash and cash equivalents Cash Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Total operating expenses Operating Expenses Weighted Average Exercise Price, Warrants Vested And Expected To Vest Weighted Average Exercise Price, Warrants Vested And Expected To Vest Weighted Average Exercise Price, Warrants Vested And Expected To Vest Document Transition Report Document Transition Report Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Marketable securities Marketable Securities Other long-term liabilities Other Liabilities, Noncurrent Warrants, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term warrant outstanding Weighted Average Remaining Contractual Term warrant outstanding Warrants Warrant [Member] Schedule of Stockholders' Equity Note, Stock Options and warrants [Table] Class of Warrant or Right [Table] Other income: Nonoperating Income (Expense) [Abstract] Less than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year Level 2 Fair Value, Inputs, Level 2 [Member] Document Quarterly Report Document Quarterly Report Options, Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Measurement Frequency [Domain] Measurement Frequency [Domain] Equity [Abstract] Equity [Abstract] Assets, fair value disclosure Assets, Fair Value Disclosure Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Options, Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Statement [Line Items] Statement [Line Items] Options, Vested and expected to vest (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Greater than one year Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Entity File Number Entity File Number Options, Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Weighted average remaining lease term for operating leases (in years) Operating Lease, Weighted Average Remaining Lease Term Statement [Table] Statement [Table] Preferred stock, shares issued Preferred Stock, Shares Issued Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Options, Vested, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Share-based compensation expense Share-based Payment Arrangement, Expense Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants, Expired (in dollars per share) Weighted Average Exercise Price, Warrants Expired Weighted Average Exercise Price, Warrants Expired Balance Sheet Location [Axis] Balance Sheet Location [Axis] Basic and diluted income (loss) per share Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Common stock, $0.001 par value, authorized 500,000,000 shares; issued and outstanding, 15,585,194 and 10,528,689 shares at June 30, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Caladrius Biosciences, Inc. common stockholders (in usd per share) Earnings Per Share, Basic and Diluted Term of agreement (in months) Term Of Agreement Term Of Agreement Less - net income attributable to noncontrolling interests Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Document Fiscal Year Focus Document Fiscal Year Focus Entity Small Business Entity Small Business Amortization of accrued grant funding to offset expense Amortization Of Accrued Grant Funding Liability To Offset Expense Amortization Of Accrued Grant Funding Liability To Offset Expense Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Funding of grant award Funding Of Grant Award, Cash Received Funding Of Grant Award, Cash Received Warrants, Forfeited (in shares) Warrants Canceled Warrants Canceled H.C. Wainwright Sales Amended Agreement H.C. Wainwright Sales Amended Agreement [Member] H.C. Wainwright Sales Amended Agreement [Member] Number of shares sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Entity Current Reporting Status Entity Current Reporting Status Price of shares sold (in dollars per share) Sale of Stock, Price Per Share Aggregate market of common stock held by non-affiliates Aggregate Market Value Of Common Stock, Non-Affiliates Aggregate Market Value Of Common Stock, Non-Affiliates Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] US Equity Plan [Member] US Equity Plan [Member] US Equity Plan [Member] Proceeds from issuance of stock Proceeds from Issuance of Common Stock General and administrative Selling, General and Administrative Expenses [Member] Amendment Flag Amendment Flag Subsequent Event [Table] Subsequent Event [Table] Stock Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Share-based compensation (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Schedule of Total Compensation Cost Related to Nonvested Awards Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Weighted average estimated fair value of restricted stock issued Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent) Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase Schedule of Assets Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock, shares issued Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other Other Accrued Liabilities, Current Share-based compensation Issuance of Stock and Warrants for Services or Claims Operating lease liabilities Present value of lease liabilities Operating Lease, Liability Available-for-Sale-Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Measurement Frequency [Axis] Measurement Frequency [Axis] Project [Domain] Project [Domain] Financial Instruments [Domain] Financial Instruments [Domain] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total Caladrius Biosciences, Inc. stockholders' equity Stockholders' Equity Attributable to Parent Other long-term liabilities Other Noncurrent Liabilities [Member] Progress payment received on grant award Progress Payment On Grant Award, Cash Received Progress Payment On Grant Award, Cash Received Liabilities and Equity, Total Liabilities and Equity Annual limitation on usage of net operating losses Net Operating Loss Analysis, Annual Limitation Net Operating Loss Analysis, Annual Limitation Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Entity Address, City or Town Entity Address, City or Town Salaries, employee benefits and related taxes Employee-related Liabilities, Current Subsequent Events Subsequent Events [Text Block] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Grants awarded Grants Receivable Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Total Caladrius Biosciences, Inc. Stockholders' Equity Parent [Member] Balance Sheet Captions Assets and Liabilities, Lessee [Abstract] Other assets Other Assets [Member] Financial Instrument [Axis] Financial Instrument [Axis] Aggregate offering amount authorized per agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Cost Debt Securities, Available-for-sale, Amortized Cost Deferred Revenue Arrangement [Line Items] Deferred Revenue Arrangement [Line Items] Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Schedule of Marketable Securities Marketable Securities [Table Text Block] Warrants, Granted (in shares) Warrants Granted Warrants Granted Equity Component [Domain] Equity Component [Domain] Total Cash, Cash Equivalents, and Short-term Investments Accounts payable, accrued liabilities and other liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Income Statement Location [Axis] Income Statement Location [Axis] Unrealized gain (loss) on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Total fair value of shares vested APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Total share-based compensation expense Income Statement Location [Domain] Liabilities Liabilities [Abstract] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Warrants Outstanding, End of Period (in dollars per share) Weighted Average Exercise Price, Warrants Outstanding Weighted Average Exercise Price, Warrants Outstanding Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Property and equipment, net Property, Plant and Equipment, Net Schedule of Available-for-sale Securities Reconciliation Schedule of Available-for-sale Securities Reconciliation [Table Text Block] General and administrative Selling, General and Administrative Expense Entity Tax Identification Number Entity Tax Identification Number Warrants Weighted Average Exercise Price [Roll Forward] Warrants Weighted Average Exercise Price [Roll Forward] Warrants Weighted Average Exercise Price [Roll Forward] Warrants expiration term Warrants and Rights Outstanding, Term Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Share-Based Compensation Share-based Payment Arrangement [Text Block] Net (loss) income attributable to Caladrius Biosciences, Inc. common stockholders Net Income (Loss) Attributable to Parent Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three 2020 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Other assets Other Assets, Noncurrent Total other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax Net proceeds from issuance of common stock Stock Issued During Period, Value, New Issues Leases [Abstract] Leases [Abstract] Total assets Assets Accrued Liabilities [Abstract] Accrued Liabilities [Abstract] Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Operating Expenses: Operating Expenses [Abstract] CD34 cell technology Ischemic Repair CD34 Cell Technology [Member] Ischemic Repair CD34 Cell Technology [Member] Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Operating loss carryforwards Operating Loss Carryforwards Earnings Per Share [Abstract] Earnings Per Share [Abstract] Title of 12(b) Security Title of 12(b) Security Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Finance Minimum Lease Payments Finance Lease, Liability, Payment, Due [Abstract] CIRM upfront funding -- current Accrued grant funding Accrued Grant Funding Accrued Grant Funding Subsequent Event Type [Axis] Subsequent Event Type [Axis] Available for sale securities - net unrealized (loss) income OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Antidilutive Securities [Axis] Antidilutive Securities [Axis] Stockholders' Equity Stockholders' Equity Attributable to Parent [Abstract] Number of shares called by warrants issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Concentration of Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Value of restricted stock issued Stock Issued During Period, Value, Restricted Stock Award, Gross Gross price for stock transaction Proceeds from stock transaction Sale of Stock, Consideration Received on Transaction Lincoln Park Agreement Lincoln Park Agreement [Member] Lincoln Park Agreement [Member] Total liabilities Liabilities Warrants, Vested and expected to vest, Aggregate Intrinsic Value Aggregate Intrinsic Value, Warrants vested and expected to vest Aggregate Intrinsic Value, Warrants vested and expected to vest Options, Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Warrants, Forfeited (in dollars per share) Weighted Average Exercise Price, Warrants Canceled Weighted Average Exercise Price, Warrants Canceled Warrants, Granted (in dollars per share) Weighted Average Exercise Price, Warrants Granted Weighted Average Exercise Price, Warrants Granted Expected weighted-average period in years of compensation cost to be recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Options, Vested and expected to vest, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Entity Filer Category Entity Filer Category Schedule Share-based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Common Stock Common Stock [Member] Sale of NOLs, value Sale Of Net Operating Losses, NJEDA Program, Value Sale Of Net Operating Losses, NJEDA Program, Value Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Market capitalization used in net operating loss analysis Market Capitalization Used In Net Operating Loss Analysis Market Capitalization Used In Net Operating Loss Analysis Level 1 Fair Value, Inputs, Level 1 [Member] Warrants Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value, Warrants Outstanding Aggregate Intrinsic Value, Warrants Outstanding Warrants, Vested, Aggregate Intrinsic Value Aggregate Intrinsic Value, Warrants vested Aggregate Intrinsic Value, Warrants vested Commitment shares issued as consideration per agreement (in shares) Stock Issued During Period, Shares, Issued As Consideration Stock Issued During Period, Shares, Issued As Consideration Research Funding Research, Development, and Computer Software Disclosure [Text Block] Warrants, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Net proceeds from issuance of common stock (in shares) Stock issued (shares) Stock Issued During Period, Shares, New Issues Additional Paid in Capital Additional Paid-in Capital [Member] Commission on gross proceeds due to third party (percent) Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Money market funds Money Market Funds [Member] Class of Stock [Line Items] Class of Stock [Line Items] Options, Vested and expected to vest, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Options, Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Accrued Liabilities [Member] Accounts Payable and Accrued Liabilities [Member] Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Total other income Nonoperating Income (Expense) Common stock, shares, outstanding Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Future Minimum Lease Payments Under Lease Agreements Lessee, Operating Lease, Liability, Maturity [Table Text Block] Stock Options Share-based Payment Arrangement, Option [Member] Warrants, Outstanding, Beginning of Period (in shares) Warrants, Outstanding, End of Period (in shares) Common Stock Warrants, Shares Common Stock Warrants, Shares Debt Securities, Available-for-sale [Abstract] Debt Securities, Available-for-sale [Abstract] Options, Vested, Weighted Average Exercise Price (in dollars per share) Weighted average estimated fair value of shares granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Stock Options Activity [Axis] Stock Options Activity [Axis] Stock Options Activity [Axis] Research and development Research and Development Expense Subsequent Events [Abstract] Subsequent Events [Abstract] Options, Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Treasury stock (shares) Treasury Stock, Shares Less than one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year Subsequent Event Subsequent Event [Member] Options, Outstanding. Beginning of Period (in dollars per share) Options, Outstanding, End of Period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Sale of Stock, Name of Transaction [Domain] Sale of Stock [Domain] Federal Domestic Tax Authority [Member] Common stock, shares authorized Common Stock, Shares Authorized Number of shares called by each warrant Class of Warrant or Right, Number of Securities Called by Each Warrant or Right May Purchase Agreement May Purchase Agreement [Member] May Purchase Agreement Total stockholders' equity Beginning Balance Ending Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital Benefit from income taxes Income Tax Expense (Benefit) Income Statement [Abstract] Income Statement [Abstract] Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent) Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period Schedule of Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Investments Classified by Contractual Maturity Date Investments Classified by Contractual Maturity Date [Table Text Block] Purchase of marketable securities Payments to Acquire Marketable Securities Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Prepaid and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Preferred stock, liquidation value Preferred Stock, Liquidation Preference, Share Preferred Stock, Liquidation Preference, Share Milestone payment received on grant award Milestone Payment On Grant Award, Cash Received Milestone Payment On Grant Award, Cash Received Local Phone Number Local Phone Number Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] April Purchase Agreement April Purchase Agreement [Member] April Purchase Agreement Nonvested Restricted Stock Shares Activity [Table Text Block] Nonvested Restricted Stock Shares Activity [Table Text Block] Income Tax Authority [Domain] Income Tax Authority [Domain] Amortized Cost Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract] Entity Address, Address Line One Entity Address, Address Line One Marketable securities - available for sale Investments, Fair Value Disclosure Project [Axis] Project [Axis] Other assets Increase (Decrease) in Other Operating Assets Entity Emerging Growth Company Entity Emerging Growth Company Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Number of offices under operating leases Number Of Offices Under Operating Leases Number Of Offices Under Operating Leases Award Type [Axis] Award Type [Axis] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment City Area Code City Area Code Preferred stock, shares authorized Preferred Stock, Shares Authorized Non- Controlling Interest in Subsidiary Noncontrolling Interest [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Accumulated Deficit Retained Earnings [Member] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Preferred stock, shares designated Preferred stock, shares designated Preferred stock, shares designated Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Options, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Share-based Payment Arrangement, Noncash Expense [Abstract] Share-based Payment Arrangement, Noncash Expense [Abstract] Net income (loss) Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Award Type [Domain] Award Type [Domain] Loss before benefit from income taxes and noncontrolling interests Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Corporate debt securities Corporate Debt Securities [Member] Trading Symbol Trading Symbol Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block] Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block] Treasury stock, at cost; 11,080 shares at June 30, 2020 and December 31, 2019 Treasury Stock, Value Private placement Private Placement [Member] Tax withholding payments on net share settlement equity awards Payment, Tax Withholding, Share-based Payment Arrangement Number of restricted stock issued Stock Issued During Period, Shares, Restricted Stock Award, Gross Income (Loss) Per Share Earnings Per Share [Text Block] Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred Cover [Abstract] Cover [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Entity Shell Company Entity Shell Company Recurring Fair Value, Recurring [Member] Options, Vested and expected to vest, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Options, Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract]